Olivier Patey
Overview
Explore the profile of Olivier Patey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
412
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Calin R, Belkacem A, Caraux-Paz P, Wagner M, Guillot H, Veziris N, et al.
Am J Trop Med Hyg
. 2020 Nov;
104(1):223-228.
PMID: 33205739
Abdominal tuberculosis (ATB) is uncommon and not very well known by clinicians. We describe the characteristics, evolution, and treatment of patients with ATB in two large hospitals in the Paris...
2.
Patey O, McCallin S, Mazure H, Liddle M, Smithyman A, Dublanchet A
Viruses
. 2019 Jan;
11(1).
PMID: 30597868
The history of phage therapy started with its first clinical application in 1919 and continues its development to this day. Phages continue to lack any market approval in Western medicine...
3.
Combes J, Heard I, Poizot-Martin I, Canestri A, Lion A, Piroth L, et al.
J Infect Dis
. 2018 Feb;
217(10):1535-1543.
PMID: 29394362
Background: We assessed prevalence and risk factors for anal human papillomavirus (HPV) in human immunodeficiency virus (HIV)-positive men who have sex with men (MSM), who are at high-risk of HPV-related...
4.
Belchior E, Henry S, Badell E, Collet L, Benoit-Cattin T, de Montera A, et al.
Emerg Infect Dis
. 2017 Jun;
23(7):1218-1220.
PMID: 28628446
Epidemiology of diphtheria in the southwestern Indian Ocean is poorly documented. We analyzed 14 cases of infection with toxigenic Corynebacterium diphtheriae reported during 2007-2015 in Mayotte, a French department located...
5.
Belkacem A, Jacquier H, Goubard A, Mougari F, Ruche G, Patey O, et al.
J Antimicrob Chemother
. 2016 Jun;
71(9):2471-8.
PMID: 27301565
Objectives: The objective of this study was to determine the prevalence and mechanisms of azithromycin resistance of Neisseria gonorrhoeae French isolates from 2013 to 2014. Methods: N. gonorrhoeae samples isolated...
6.
Lortholary O, Roussillon C, Boucherie C, Padoin C, Chaix M, Breton G, et al.
J Antimicrob Chemother
. 2015 Dec;
71(3):783-93.
PMID: 26679250
Background: HIV-infected patients with TB need simplified, effective and well-tolerated antiretroviral regimens. Methods: The French ANRS 129 BKVIR open trial evaluated the once-daily tenofovir DF/emtricitabine and efavirenz combination, started within...
7.
Debarbieux L, Pirnay J, Verbeken G, De Vos D, Merabishvili M, Huys I, et al.
FEMS Microbiol Lett
. 2015 Dec;
363(2):fnv225.
PMID: 26656541
No abstract available.
8.
Pirnay J, Blasdel B, Bretaudeau L, Buckling A, Chanishvili N, Clark J, et al.
Pharm Res
. 2015 Jan;
32(7):2173-9.
PMID: 25585954
The worldwide antibiotic crisis has led to a renewed interest in phage therapy. Since time immemorial phages control bacterial populations on Earth. Potent lytic phages against bacterial pathogens can be...
9.
Chakrabarti L, Boucherie C, Bugault F, Cumont M, Roussillon C, Breton G, et al.
AIDS
. 2014 May;
28(11):1593-602.
PMID: 24865974
Objective: Patients coinfected with HIV and Mycobacterium tuberculosis frequently experience a paradoxical worsening of tuberculosis (TB) symptoms early after the initiation of combination antiretroviral therapy (cART). This immune reconstitution inflammatory...
10.
Grinsztejn B, de Castro N, Arnold V, Veloso V, Morgado M, Pilotto J, et al.
Lancet Infect Dis
. 2014 Apr;
14(6):459-67.
PMID: 24726095
Background: Concurrent treatment of HIV and tuberculosis is complicated by drug interactions. We explored the safety and efficacy of raltegravir as an alternative to efavirenz for patients co-infected with HIV...